Your pathways. Our assays.

ApoCell scientists can provide expert guidance in helping clients to optimize the data obtained from expensive and unique study subjects’ samples.

ApoCell’s founder Darren Davis, Ph.D., and other company scientists are recognized experts in the study of cell signaling in the molecular pathways of Angiogenesis. The company has conducted testing in over 60 clinical trials of targeted agents where expression of angiogenic protein activity is detected and quantified. This includes several classes of RTKs (EGF, PDGF, VGEF), cell proliferation pathways (mTOR/Akt) and DNA damage and repair.